Sangui Biotech Intl Inc (SGBI) 0.0045 $SGBI Sangui

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sangui Biotech Intl Inc (SGBI) 0.0045 $SGBI

Sangui BioTech International Publishes Preliminary Figures for First Half Year
BusinessWire - Mon Feb 01, 10:00AM CST
--Increase in Granulox royalty income by 28%
SBH: 27.06 (+0.18)

Sangui BioTech International Files S-1 Registration Statement with the SEC
BusinessWire - Fri Jun 26, 5:30AM CDT
Sangui Biotech International, Inc. has filed a preliminary S-1 Registration Statement with the Securities and Exchange Commission. It is being expected that the SEC will declare the Prospectus effective within the next couple of weeks. The exact timeline depends on SEC approval procedures which cannot be anticipated by the company. The S-1 becoming effective is prerequisite for Sangui to start drawing upon the financial framework agreement with US investor Southridge as announced on May 12, 2015.
SBH: 27.06 (+0.18)

Sangui BioTech: Lower Revenues in the Third Quarter
BusinessWire - Fri May 15, 5:00AM CDT
For the nine months (as of March 31, 2015) of its 2015 financial year Sangui BioTech International, Inc. reports revenues from product sales and royalties in the amount of USD116,560, an increase of 29.9% over the revenues in the first nine months of the financial year 2014 when revenues amounted to USD89,741 (previous period numbers not adjusted for exchange rate changes). In the third quarter (January through March 2015) revenues amounted to USD11,654 a decrease of 62.6% as compared with the most recent quarter(October through December 2014). According to information provided by global licensee SastoMed GmbH revenues from license fees are expected to increase significantly over the remaining quarters of the calendar year after the slump of the March quarter.
SBH: 27.06 (+0.18)

Sangui BioTech International Secures Financial Framework of $5 Million over Three Years
BusinessWire - Tue May 12, 8:00AM CDT
Sangui Biotech International, Inc. has signed an agreement securing a financial framework of USD 5 million. Under the terms of this agreement Sangui Biotech International, Inc. acquires the right to sell shares to a fund of Southridge LLC, an institutional investor, located in Connecticut and New York in the amount of up to $5 million over a period of three years. The dilution of existing shareholders is limited to a maximum of 25 million shares of common stock. The agreement is subject to Sangui filing a S-1 registration statement with the SEC.
SBH: 27.06 (+0.18)

Sangui BioTech: Revenues Slightly Improved in the First Half of the 2015 Financial Year
BusinessWire - Thu Feb 12, 5:00AM CST
For the first half (as of December 31, 2014) of its 2015 financial year Sangui BioTech International, Inc. reports revenues from product sales and royalties in the amount of USD104,906 an increase of 74.0% over the revenues in the first half of the financial year 2014. In the second quarter (October through December 2014) revenues amounted to USD31,166 a decrease of 57.7% as compared with the most recent quarter(July through September 2014).

Sangui BioTech: Revenues Improved in the First Quarter of the 2015 Financial Year
BusinessWire - Thu Nov 13, 5:00AM CST
For the first quarter (as of September 30, 2014) of its 2015 financial year Sangui BioTech International, Inc. reports revenues from product sales and royalties in the amount of USD73,470 (Q1/2013: USD26,527). This is an improvement of 73% as compared with the fourth quarter of the previous financial year (as of June 30, 2014).
SBH: 27.06 (+0.18)

Sangui BioTech International officially approved as trading on OTCQB
BusinessWire - Thu Nov 06, 5:36AM CST
OTC Markets Group has officially informed Sangui Biotech International, Inc., that the application of the company for continued trading on the OTCQB venture market place for early stage and developing companies was approved of today. Subsequent to the reorganization of the OTC markets, resulting in higher transparency levels and significantly improved services for issuers and investors in particular on OTCQB, Sangui has submitted all the mandatory documents and successfully met all of the initial requirements.
SBH: 27.06 (+0.18)

Sangui BioTech Yields Revenues of over USD70,000 in Q1 2015 According to Preliminary Figures
BusinessWire - Tue Oct 07, 1:22PM CDT
According to preliminary, unaudited figures Sangui BioTech International, Inc. yielded revenues from royalties and product sales of more than USD70,000 in the course of the first quarter of its financial year 2015, ended September 30, 2014. In the fourth quarter of the 2014 financial year (ended June 30, 2014) revenues had amounted to USD43,729; in the first quarter of its financial year 2014 (ended September 30, 2014) the company reported revenues of USD26,527.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 460

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 349

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 448

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 237

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 375

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 285

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 210

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 245

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 412

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading

Top 5 Most Recently Viewed Articles

Onewater Marine Shares Hit Bottom as Recovery Efforts Begin

Updated Category News Views 96

Onewater Marine's Stock Reaches 52-Week Low In a challenging year for Onewater Marine (NASDAQ: ONEW) Inc., the company's stock has plummeted to a 52-week low of $18.43. This striking downturn indicates a significant one-year decline, with the stock value decreasing by an alarming 42.49%. Despite this setback, analysts maintain a consensus Buy rating, with price targets...

Continue Reading
Exploring McEwen's Upcoming Results and Strategy Insights

Updated Category News Views 238

Join McEwen for the Q2 2025 Results Conference Call TORONTO — McEwen Inc. (NYSE: MUX) (TSX: MUX) is thrilled to announce an upcoming conference call to discuss the financial results for the second quarter of 2025. This event promises to be an excellent opportunity for shareholders and interested parties to gain insights into the Company’s performance and future...

Continue Reading
Eminent Gold Reinitiates Drilling at Hot Springs Range Project

Updated Category News Views 144

Resuming Drilling at Hot Springs Range Project Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) has resumed core drilling at its Hot Springs Range Project, marking a pivotal moment in its exploration journey. This renewed activity follows the successful completion of its initial drilling campaign, which revealed gold mineralization in multiple holes. The project, situated...

Continue Reading
Exclusive Interview with Donald Trump Aired on FOX Noticias

Updated Category News Views 537

Exclusive Interview Scheduled on FOX Noticias FOX Noticias is set to air an exclusive two-part interview featuring President Donald Trump. The interviews are scheduled for two consecutive days and will be hosted by Rachel Campos-Duffy. This marks a significant moment as it is President Trump's first engagement with the media following notable recent announcements...

Continue Reading
How Immediate Water Filtration Helps Communities Combat Lead Risks

Updated Category News Views 77

Immediate Water Filtration: A Game Changer for Communities In a recent study, experts have highlighted how point-of-use (POU) filtration systems can significantly mitigate lead contamination in drinking water, providing a timely solution for communities grappling with aging infrastructure. This approach is essential, especially as municipalities prepare to comply with...

Continue Reading